Greenville, NC – According to filings with the U.S. Securities and Exchange Commission, Perfusio is raising $8,500,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Monte Tucker played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Perfusio
Perfusio is bringing to market a radical platform technology that gives surgeons the worlds first non-invasive, real-time surgical imaging of intact and diseased tissue. With Perfusios innovative technology, surgeons can finally see true perfusion and blood flow, accurately and objectively, without subjecting the patient to delays or dyes. This solution addresses the principal cause of most major surgical complications today. Certes by Perfusio is FDA-cleared for use in all surgical specialties and procedures. It provides surgeons a revolutionary way to see beyond visible light and make more informed decisions before, during, and after a procedure. Using dynamic physiologic data and analytics, the benefit is clear: greater patient safety, objective data for surgeons, and improved outcomes and cost-effectiveness for providers. Perfusio was founded in 2014 in Greenville, North Carolina, as RFPi, Inc. The company changed its name in 2021 to more accurately reflect its mission to transform surgical practice through a new standard of care.

To learn more about Perfusio, visit http://perfusio.com/

Contact:
Monte Tucker, Chief Executive Officer
252-656-0404
https://www.linkedin.com/in/monte-b-tucker-aa60a51/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved